Compare WST & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | EL |
|---|---|---|
| Founded | 1923 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 34.9B |
| IPO Year | N/A | 1995 |
| Metric | WST | EL |
|---|---|---|
| Price | $274.90 | $109.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 20 |
| Target Price | ★ $346.78 | $95.80 |
| AVG Volume (30 Days) | 742.7K | ★ 3.8M |
| Earning Date | 10-23-2025 | 02-03-2026 |
| Dividend Yield | 0.32% | ★ 1.30% |
| EPS Growth | ★ 0.17 | N/A |
| EPS | ★ 6.75 | N/A |
| Revenue | $3,017,900,000.00 | ★ $14,446,000,000.00 |
| Revenue This Year | $7.01 | $7.34 |
| Revenue Next Year | $6.20 | $4.07 |
| P/E Ratio | $40.37 | ★ N/A |
| Revenue Growth | ★ 4.92 | N/A |
| 52 Week Low | $187.43 | $48.37 |
| 52 Week High | $348.90 | $110.37 |
| Indicator | WST | EL |
|---|---|---|
| Relative Strength Index (RSI) | 53.29 | 66.76 |
| Support Level | $264.92 | $100.13 |
| Resistance Level | $275.56 | $110.37 |
| Average True Range (ATR) | 7.64 | 2.98 |
| MACD | 0.06 | 0.50 |
| Stochastic Oscillator | 53.47 | 87.66 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%), with top-selling brands such as Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.